Floatz logo

Zofran

Transarterial Chemoembolization

The Second Affiliated Hospital of Chongqing Medical UniversityPhase 4 / ApprovedActive
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Transarterial Chemoembolization cohort.

Asset / SponsorPhaseRating
HYDROMORPHONE HYDROCHLORIDE CII
First Affiliated Hospital, Sun Yat-Sen University
Phase 4BB
Theprubicin
Xinrui Zhu，MD
Phase 3BB
Amitriptyline
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB
SUFENTANYL
The Second Affiliated Hospital of Chongqing Medical University
Phase 4BB
Ethiodized Oil
Xinrui Zhu，MD
Phase 3BB

View all 13 →

Same molecule, other indications

Zofran is also rated in:

NauseaDormant
BBB
Indicative ·
73 / 100
View asset →
VomitingDormant
BBB
Indicative ·
73 / 100
View asset →
Non-Hodgkin's LymphomaDormant
BB
Indicative ·
71 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →